Treatment of patients with primary retroperitoneal sarcoma: predictors of outcome from an Australian specialist sarcoma centre. Issue 11 (4th October 2018)

• Record Type: Journal Article
• Authors: Snow, Hayden A.; Hitchen, Tatiana X.; Head, Jessica; Herschtal, Alan; Bae, Susie; Chander, Sarat; Chu, Julie; Hendry, Shona; Ngan, Samuel Y.; Desai, Jayesh; Choong, Peter F. M.; Henderson, Michael; Gyorki, David E.
• Is Part Of: ANZ journal of surgery. Volume 88:Issue 11(2018)
• Page Start: 1151
• Page End: 1157
• Publication Date: 2018-10-04
• Subjects: leiomyosarcoma -- liposarcoma -- recurrence -- sarcoma -- tertiary healthcare; Surgery -- Periodicals; 617.005
• DOI: 10.1111/ans.14842
• Languages: English
• ISSNs: 1445-1433

Abstract

Abstract : Background: Several unanswered questions surround the management of retroperitoneal sarcoma (RPS). Guidelines recommend treatment by a multidisciplinary team at a specialized referral centre. The objective of this study was to describe the management of RPS at an Australian specialist sarcoma centre, comparing outcomes to international standards and analysing for predictors of local failure. Methods: A retrospective review of a prospectively maintained database was performed on patients with RPS treated between 2008 and 2016. A 5‐year outcome analyses focussed on patients undergoing curative‐intent surgery for primary, non‐metastatic RPS. Results: Eighty‐eight patients underwent surgery for primary RPS. Five‐year overall survival was 66%, 5‐year freedom from local recurrence was 65% and 5‐year freedom from distant metastasis was 71%. Overall survival was associated with tumour grade (hazard ratio (HR) 6.1, P < 0.001) and histologic organ invasion (HR 5.7, P < 0.001). Variables associated with improved freedom from local recurrence were macroscopically complete resection (HR 0.14, P < 0.001) and neoadjuvant radiotherapy (HR 0.33, P = 0.014). Treatment at a specialist sarcoma centre was associated with a higher rate of preoperative biopsy and neoadjuvant radiotherapy (both with P < 0.001). There was a trend towards improved local control for patients undergoing surgery at a specialist centre ( P = 0.055). Conclusion: This is the largest Australian series of RPS and outcomes are comparable to major international sarcoma centres. Patients treated at a specialist centre had higher rates of preoperative diagnosis and tailored therapy which was associated with improved outcomes. Patients with suspected RPS should be referred to a specialist centre for optimal preoperative evaluation and multidisciplinary management.